Content Syndication Downloads Cardinal Health
10 years of biosimilars
2025 marks 10 years since the first biosimilar came to market. Since 2015, the healthcare industry has seen tremendous growth in the biosimilar market across most therapeutic areas including Ophthalmology.
Introducing Cardinal Health’s newest report: 10 years of biosimilars.
In this report, Cardinal Health looks back on the major milestones from the past 10 years, which have transformed the biosimilars landscape including:
-
Physician and patient adoption
-
Overcoming barriers to optimize practices
-
Market sustainability with manufacturers
-
Biosimilars launching into new therapeutic areas
-
The evolving federal and state legislation
Sponsored By
